MetaSafe AB is a reputable brand that offers expertise in metabolite analysis in the ADME (Absorption, Distribution, Metabolism, and Excretion) field. Founded in 2013 by ex Astra Zeneca biotransformation and ADME scientists, MetaSafe aims to maintain and develop biotransformation expertise, making it available to any pharmaceutical company. In 2018, MetaSafe merged with Admescope Sweden after being acquired by Admescope, which is now a Symeres company.

In 2022, MetaSafe underwent a transfer to the CTR group in Sweden, ensuring their continued provision of high-quality metabolite analysis services. MetaSafe specializes in Metabolites in Safety testing and radiolabel-assisted metabolite analysis. With a team of experienced and passionate experts, MetaSafe offers extensive knowledge and support to pharmaceutical companies seeking to understand and evaluate the safety profiles of their products.

Located in Södertälje, Sweden, MetaSafe is dedicated to delivering exceptional services and fostering productive collaborations. If you have upcoming projects that require expert guidance, don't hesitate to reach out to MetaSafe for a consultation. Trust MetaSafe to provide the expertise you need for successful drug development